Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.
Baykara M, Benekli M, Ekinci O, Irkkan SC, Karaca H, Demirci U, Akinci MB, Unal OU, Dane F, Turkoz FP, Balakan O, Eser EP, Ozturk SC, Ozkan M, Oksuzoglu B, Sevinc A, Demir N, Harputluoglu H, Yalcin B, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Baykara M, et al. Among authors: yalcin b. J Gastrointest Surg. 2015 Sep;19(9):1565-71. doi: 10.1007/s11605-015-2888-y. Epub 2015 Jul 16. J Gastrointest Surg. 2015. PMID: 26179664
ABO and Rh blood groups and risk of colorectal adenocarcinoma.
Urun Y, Ozdemir NY, Utkan G, Akbulut H, Savas B, Oksuzoglu B, Oztuna DG, Dogan I, Yalcin B, Senler FC, Onur H, Demirkazik A, Zengin N, Icli F. Urun Y, et al. Among authors: yalcin b. Asian Pac J Cancer Prev. 2012;13(12):6097-100. doi: 10.7314/apjcp.2012.13.12.6097. Asian Pac J Cancer Prev. 2012. PMID: 23464411 Free article.
Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
Ozdemir N, Abali H, Vural M, Yalcin S, Oksuzoglu B, Civelek B, Oguz D, Bostanci B, Yalcin B, Zengin N. Ozdemir N, et al. Among authors: yalcin b, yalcin s. Cancer Chemother Pharmacol. 2014 Dec;74(6):1139-47. doi: 10.1007/s00280-014-2586-6. Epub 2014 Sep 19. Cancer Chemother Pharmacol. 2014. PMID: 25234436 Clinical Trial.
Resistance to androgen-pathway drugs in prostate cancer.
Şendur MA, Akıncı MB, Yalçın B. Şendur MA, et al. Among authors: yalcin b. N Engl J Med. 2014 Dec 4;371(23):2233. doi: 10.1056/NEJMc1412594. N Engl J Med. 2014. PMID: 25470701 No abstract available.
581 results